IPP Bureau
WHO prequalifies Syngenta’s innovative insecticide Sovrenta
By IPP Bureau - April 23, 2025
A new weapon in the global fight against malaria
Paras Healthcare introduces radiation oncology facility at Ranchi
By IPP Bureau - April 23, 2025
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Gujarat CM Bhupendra Patel inaugurates 217-bed cancer hospital in Ahmedabad
By IPP Bureau - April 22, 2025
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
AstraZeneca, Daiichi Sankyo announce Enhertu plus pertuzumab demonstrated clinically meaningful improvement as 1st-line therapy for patients with metastatic breast cancer
By IPP Bureau - April 22, 2025
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
Vgenomics and Meril Genomics collaborate to revolutionise precision medicine
By IPP Bureau - April 22, 2025
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
FUJIFILM launches advanced therapeutic endoscopy system in India
By IPP Bureau - April 22, 2025
The system is powered by advanced imaging innovations such as Amber-red Color Imaging, Triple Noise Reduction, and Extended Dynamic Range Image Processing
Abbott India elevates Maithilee Pathare Mistry as CFO
By IPP Bureau - April 21, 2025
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
MoS Health Jadhav inaugurates FSSAI’s stakeholder consultation on sustainable packaging
By IPP Bureau - April 21, 2025
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system
By IPP Bureau - April 21, 2025
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
Aptar commences clinical study to accelerate FDA approval of SmartTrack
By IPP Bureau - April 19, 2025
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
GSK’s blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma
By IPP Bureau - April 19, 2025
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
Zydus Medtech inks pact with Braile Biomedica to commercialise TAVI technology
By IPP Bureau - April 18, 2025
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
CCI approves merger between Aster DM Healthcare and Quality Care India
By IPP Bureau - April 18, 2025
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Rockwell Automation empowers NKP Pharma achieve regulatory compliance
By IPP Bureau - April 17, 2025
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Glenmark Pharmaceuticals USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablet
By IPP Bureau - April 17, 2025
According to IQVIATM sales data for the 12-month period ending February 2025, the Adderall Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg market3 achieved annual sales of approximately $421.7 million.
